Workflow
*ST富吉(688272) - 2021 Q4 - 年度财报
FJRFJR(SH:688272)2022-05-29 16:00

Financial Performance - The company achieved a net profit attributable to ordinary shareholders of RMB 76,443,601.71 for the year 2021, with a total distributable profit of RMB 114,934,322.84 as of December 31, 2021[6]. - The proposed cash dividend distribution is RMB 1.01 per 10 shares (including tax), amounting to a total of RMB 7,676,000, which represents 10.04% of the net profit attributable to shareholders for the year[6]. - The company's operating revenue for 2021 was CNY 317.93 million, a decrease of 2.87% compared to CNY 327.32 million in 2020[21]. - The net profit attributable to shareholders of the listed company was CNY 66.01 million, down 22.32% from CNY 84.97 million in the previous year[21]. - The net cash flow from operating activities decreased by 283.57%, resulting in a negative cash flow of CNY 86.24 million, primarily due to slower sales collection and increased cash payments to employees[23]. - The company's total assets increased by 110.76% year-on-year, mainly due to net fundraising of CNY 369.84 million from the initial public offering[23]. - The basic earnings per share decreased by 20.63% to CNY 1.27 from CNY 1.60 in 2020[23]. - The net assets attributable to shareholders of the listed company grew by 192.07% to CNY 678.64 million, primarily due to the increase in capital reserves from the IPO[23]. - The weighted average return on net assets decreased by 39.43 percentage points to 23.01% from 62.44% in the previous year[23]. - The company reported quarterly revenues of CNY 59.03 million, CNY 95.20 million, CNY 69.38 million, and CNY 94.32 million for Q1 to Q4 respectively[26]. Research and Development - Research and development expenses accounted for 12.09% of operating revenue, an increase of 1.97 percentage points compared to 10.12% in 2020[23]. - R&D investment totaled 38.44 million yuan, representing a year-on-year increase of 16.06% and accounting for 12.09% of revenue[33]. - The company has a total of 281 employees, with 114 in R&D, making up approximately 40.57% of the workforce[34]. - The company holds 63 valid patents, including 17 invention patents, 30 utility model patents, and 16 design patents[34]. - The company has developed advanced technologies in infrared thermal imaging, enhancing production efficiency and product quality through automation[80]. - The company has implemented automated testing technologies for infrared lenses, improving production efficiency and reliability[80]. - The company has developed advanced core technologies, including image compensation technology and low-power large-area sensor driving technology, which enhance infrared product stability and reduce overall power consumption[77]. - The company achieved a total R&D investment of ¥38,442,411.38 in 2021, representing a 16.06% increase from ¥33,121,810.75 in the previous year[85]. - The number of R&D personnel increased to 114, making up 40.57% of the total workforce, up from 90 in the previous year[107]. Market and Product Development - The company plans to continue expanding its market presence and investing in new product development to drive future growth[23]. - The company specializes in the research, production, and sales of infrared thermal imaging products and systems, expanding into solid-state micro-light, short-wave, ultraviolet, and visible light technologies[36]. - The company is focusing on expanding its civilian product market, particularly in high-value thermal imaging and optoelectronic systems[120]. - The company is committed to expanding its presence in both military and civilian markets, focusing on technology R&D and market development[173]. - The company is focusing on enhancing its product offerings in both cooling and non-cooling categories, with a notable shift in revenue distribution observed in the thermal imaging segment[132]. Governance and Compliance - The company has not disclosed any special arrangements for corporate governance[8]. - The company has received a standard unqualified audit report from Rongcheng Accounting Firm[5]. - The company has established a system for managing insider information, ensuring confidentiality prior to disclosures[179]. - The company strictly adhered to information disclosure obligations, ensuring timely and accurate announcements throughout the reporting period[179]. - The company has no significant issues regarding independence from its controlling shareholder, ensuring autonomous operational capacity[180]. Risks and Challenges - The company has detailed various risks and countermeasures in its report, which investors are advised to review[4]. - The company faces risks related to market competition, particularly due to its relatively short development history compared to industry leaders[116]. - The company faces risks related to U.S. trade restrictions and the ongoing impact of the COVID-19 pandemic on its operations[124]. - The company is addressing governance risks as it scales, emphasizing the need for enhanced management capabilities to adapt to rapid business growth[118]. Financial Management - The company has implemented a comprehensive quality management system in accordance with ISO9001 standards, ensuring strict quality control throughout the product lifecycle[112]. - The company reported a gross profit margin improved from 49.20% in 2020 to 52.69% in 2021[121]. - The company experienced a net cash outflow from operating activities of CNY 86.24 million, a decline of 283.57% compared to the previous year[128]. - The company’s inventory value increased from CNY 157.03 million at the end of 2020 to CNY 166.09 million at the end of 2021[121]. - The company reported a total revenue of 13,850,000.00 for the ground surveillance optical system, with a completion rate of 98.5% compared to the previous period[96]. Strategic Initiatives - The company plans to use part of the idle raised funds to temporarily supplement working capital, as approved on December 20, 2021[199]. - The company is in the process of revising its articles of association and related governance rules[199]. - The company aims to enhance its R&D capabilities and expand its business scale through strategic investments and partnerships[170]. - The company intends to strengthen cooperation with upstream and downstream partners in the industry chain to reduce costs and enhance efficiency[172].